The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[3-(4-Amino-cyclohexylamino)-5-chloro-6-methyl-2-oxo-2H-pyrazin-1-yl]-N-[2-(1H-imidazol-4-yl)-ethyl]-acetamide TFA ID: ALA3085010
PubChem CID: 44394710
Max Phase: Preclinical
Molecular Formula: C20H27ClF3N7O4
Molecular Weight: 407.91
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(Cl)nc(N[C@H]2CC[C@H](N)CC2)c(=O)n1CC(=O)NCCc1c[nH]cn1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C18H26ClN7O2.C2HF3O2/c1-11-16(19)25-17(24-13-4-2-12(20)3-5-13)18(28)26(11)9-15(27)22-7-6-14-8-21-10-23-14;3-2(4,5)1(6)7/h8,10,12-13H,2-7,9,20H2,1H3,(H,21,23)(H,22,27)(H,24,25);(H,6,7)/t12-,13-;
Standard InChI Key: BIHSBTZFUNZNDJ-UBRLZZGHSA-N
Molfile:
RDKit 2D
35 36 0 0 0 0 0 0 0 0999 V2000
-2.4333 2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4333 3.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1500 3.8583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4333 1.8500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.1083 2.0625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.7708 2.0625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 3.8583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5000 -1.0375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9333 -0.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9333 -1.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2208 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2208 0.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5000 -0.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8667 -0.2000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6458 -1.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2167 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7875 -1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0917 -0.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6750 -0.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9292 -1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2208 -2.2667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5375 -1.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2208 1.0375 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.9292 -0.2000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6375 -1.4375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3625 -1.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0750 -1.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2125 0.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3542 -1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4958 0.2125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.7833 -0.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0708 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3625 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0625 0.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7833 -1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 1 0
5 1 1 0
6 1 1 0
7 2 1 0
9 12 1 0
10 11 1 0
11 8 1 0
12 13 2 0
13 8 1 0
14 17 1 0
15 10 1 0
16 8 1 0
17 27 1 0
18 22 1 0
19 14 2 0
20 16 1 0
21 11 2 0
22 17 2 0
23 12 1 0
24 20 2 0
25 20 1 0
26 15 1 6
27 29 1 0
28 13 1 0
29 25 1 0
31 30 1 1
31 35 1 0
32 26 1 0
33 26 1 0
34 33 1 0
35 32 1 0
10 9 2 0
34 31 1 0
18 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.91Molecular Weight (Monoisotopic): 407.1837AlogP: 0.97#Rotatable Bonds: 7Polar Surface Area: 130.72Molecular Species: BASEHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.10CX Basic pKa: 10.15CX LogP: -0.68CX LogD: -3.30Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.25
References 1. Hopkins C, Neuenschwander K, Scotese A, Jackson S, Nieduzak T, Pauls H, Liang G, Sides K, Cramer D, Cairns J, Maignan S, Mathieu M.. (2004) Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation., 14 (19): [PMID:15341931 ] [10.1016/j.bmcl.2004.07.051 ]